Navigation Links
Celsis Launches RapiScreen(TM) Beverage Microbial Screening System
Date:11/20/2008

CHICAGO, Nov. 20 /PRNewswire/ -- Celsis International plc (LSE: CEL.L), the global leader in rapid microbial detection solutions for industry, today announced the launch of RapiScreen(TM) Beverage, a new assay for use on the Celsis Innovate -- the company's proven rapid microbial screening instrument for dairy products. This new rapid screening test kit extends the Celsis Innovate platform to efficiently and rapidly screen Ultra Heat Treated (UHT) and Extended Shelf Life (ESL) beverage products for microbial contamination.

The flexibility and high-throughput of the Celsis Innovate system makes it ideal for companies that produce beverage and dairy products alike. The RapiScreen Beverage kit works on everything from clear to pulpy juices, from broths to soups, with no filtering necessary.

"Many of our dairy industry customers are expanding their product portfolios to include non-dairy products such as nutritional shakes and fruit- or broth-based items," said Judy Madden, VP of the Celsis Rapid Detection division. "With the addition of the RapiScreen Beverage kit for the Innovate, the same trusted platform now can be used to test for contamination across their entire spectrum of products, quickly and efficiently."

Adenosine Triphosphate (ATP) bioluminescence is the industry standard for the rapid microbial screening of UHT and ESL beverage products. Using proprietary innovations in enzyme technology, RapiScreen Beverage for Innovate delivers reliable and consistent results on a broad range of products in 24-48 hours. Additional benefits include:

    --  Validation available on a wide variety of UHT/ESL beverage products
        including broths, soups, sport drinks, ready-to-drink teas,
        yogurt-based drinks, fruit juices and nutritional supplements
    --  Effective on low pH products
    --  Equally effective with filterable and non-filterable products
    --  Process is non-destructive, allowing for further testing if needed
    --  Validated on a wide range of microorganisms

The Celsis RapiScreen Beverage kit offers a cost-effective, rapid screening solution for the Innovate platform that drives quick results and ROI. Companies interested in learning more about RapiScreen Beverage for the Innovate can visit http://www.celsis.com/rapid for more information.

About Celsis Rapid Detection Systems

By significantly reducing the time required to test and release raw materials, in-process and finished goods, manufacturers using Celsis Rapid Detection systems realize improved cash flow and reduced working-capital requirements, while ensuring quality and increased responsiveness throughout the supply chain. Celsis' extensive client base includes many of the world's leading pharmaceutical and consumer products companies. Founded in the UK and now headquartered in Chicago, the Company has been listed on the London Stock Exchange (CEL.L) since 1993.


'/>"/>
SOURCE Celsis International plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Celsis Receives Frost & Sullivan 2008 Best Practices Award
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Novozymes Launches Enzyme to Reduce Acrylamide in Food
4. Enova Medical Launches Exos Corporation
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
7. ThirdBiotech Networking Group Launches
8. BioReliance Launches Next-Generation Genotoxicity Screening Service
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
11. Kingfisher Healthcare Launches Breakthrough Product in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... -- Research and Markets has announced the addition of ... their offering. ... The report provides separate comprehensive analytics for the US, ... World. Annual estimates and forecasts are provided for the period 2015 ... markets. Market data and analytics are derived from primary and secondary ...
(Date:2/17/2017)... 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) today ... peptide drug candidates, PTG-100 and PTG-200, at the ... and Colitis Organization (ECCO).  The ECCO congress is ... from February 15 – 18, 2017. ... Protagonist drug candidates PTG-100 and PTG-200. PTG-100, a ...
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... , February 16, 2017 ... the infusion of innovative telemedicine application, new and ... that are experiencing a boom worldwide. The healthcare ... advancement of technologies, services and new therapies for ... RQHTF) (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
(Date:2/9/2017)... -- The biomass boiler market report by Transparency Market ... globally in terms of revenue (US$ Mn) based on ... biomass boilers has been segmented on the basis of ... market based on feedstock type, has been segmented into ... crops, urban residues, and others. On the basis of ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
Breaking Biology News(10 mins):